S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
Log in
NYSEAMERICAN:OGEN

Oragenics Short Interest Ratio and Short Volume

$1.02
0.00 (0.00 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.01
Now: $1.02
$1.07
50-Day Range
$0.42
MA: $0.44
$0.54
52-Week Range
$0.36
Now: $1.02
$2.09
Volume3.80 million shs
Average Volume32.78 million shs
Market Capitalization$78.87 million
P/E RatioN/A
Dividend YieldN/A
Beta0.64

Short Interest

Oragenics (NYSEAMERICAN:OGEN) Short Interest Data

Current Short Volume3,280,000 shares
Previous Short Volume3,350,000 shares
Change Vs. Previous Month:-2.09%
Dollar Volume Sold Short$3.35 million
Short Interest Ratio / Days to Cover0.1
Last Record DateFebruary, 12 2021
Outstanding Shares46,130,000 shares
Percentage of Shares Shorted4.24%
Today's Trading Volume3,803,103 shares
Average Trading Volume32,783,590 shares
Today's Volume Vs. Average-88.40%

Short Interest Over Time


Oragenics (NYSEAMERICAN:OGEN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20213,280,000 shares $3.35 million -2.1%N/A0.1 $1.02
1/29/20213,350,000 shares $4.92 million -23.2%N/A0.1 $1.47
1/15/20214,360,000 shares $3.92 million +108.6%N/A0.2 $0.90
12/31/20201,360,000 shares $1.05 million -7.5%N/A0.2 $0.77
12/15/20201,360,000 shares $788,800.00 -7.5%N/A0.2 $0.58
11/30/20201,470,000 shares $617,400.00 -17.0%N/A0.3 $0.42
11/15/20201,770,000 shares $761,100.00 +65.4%N/A0.7 $0.43
10/30/20201,070,000 shares $502,900.00 -19.6%N/A0.4 $0.47
10/15/20201,330,000 shares $704,900.00 -14.2%N/A0.4 $0.53
9/30/20201,550,000 shares $930,000.00 -32.9%3.4%0.2 $0.60
9/15/20202,310,000 shares $1.46 million -1.3%5.1%0.3 $0.63
8/31/20202,340,000 shares $1.50 million +46.3%5.2%0.3 $0.64
8/14/20201,600,000 shares $1.12 million -59.7%3.7%0.2 $0.70
7/31/20203,970,000 shares $3.69 million +32.3%10.1%0.5 $0.93
7/15/20203,000,000 shares $3.63 million +275.6%7.9%0.4 $1.21
6/30/2020798,700 shares $1.05 million -6.9%2.0%0.2 $1.32
6/15/2020858,300 shares $703,806.00 -12.0%2.2%0.3 $0.82
5/29/2020974,800 shares $497,148.00 -25.6%2.7%0.4 $0.51
5/15/20201,310,000 shares $746,700.00 +18.0%3.6%0.5 $0.57
4/30/20201,110,000 shares $654,900.00 -36.6%2.8%0.5 $0.59
4/15/20201,750,000 shares $945,000.00 +9.4%4.5%1 $0.54
3/31/20201,600,000 shares $656,000.00 -13.4%4.1%1.3 $0.41
3/13/20201,847,100 shares $1.40 million +8.7%4.2%1.6 $0.76
2/28/20201,700,000 shares $918,000.00 +4.9%4.3%1.4 $0.54
2/14/20201,620,000 shares $1.04 million +14.9%3.8%1.8 $0.64

Oragenics (NYSEAMERICAN:OGEN) Short Interest FAQ

speech bubbles
speech bubbles











What is Oragenics' current short interest?

Short interest is the volume of Oragenics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 3,280,000 shares of OGEN short.

Is Oragenics' short interest increasing or decreasing?

Oragenics saw a decrease in short interest in February. As of February 12th, there was short interest totaling 3,280,000 shares, a decrease of 2.1% from the previous total of 3,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Oragenics' short interest compare to its competitors?

0.00% of Oragenics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Oragenics: Evofem Biosciences, Inc. (0.00%), Alpine Immune Sciences, Inc. (2.95%), Guardion Health Sciences, Inc. (0.00%), CorMedix Inc. (0.00%), Nabriva Therapeutics plc (8.33%), Tyme Technologies, Inc. (4.91%), Kezar Life Sciences, Inc. (0.00%), Cerecor Inc. (0.00%), Sernova Corp. (0.00%), and Galera Therapeutics, Inc. (1.33%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Oragenics stock?

Short selling OGEN is an investing strategy that aims to generate trading profit from Oragenics as its price is falling. To short Oragenics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Oragenics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oragenics?

A short squeeze for Oragenics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OGEN, which in turn drives the price of the stock up even further.

How often is Oragenics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGEN, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.